Back to User profile » Dr Yongjun Xue
Paper published by Dr Yongjun Xue:
Original Research
A Phase 1, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics of Iberdomide in Subjects with Mild, Moderate, or Severe Hepatic Impairment Compared with Healthy Subjects
Cheng Y, Ye Y, Gaudy A, Ghosh A, Xue Y, Wang A, Zhou S, Li Y
Clinical Pharmacology: Advances and Applications 2023, 15:9-19
Published Date: 28 February 2023